In 1999 Jerry Brunetti was diagnosed with Non-Hodgkin’s Lymphoma and given 6 months to live. He did not submit to chemotherapy, but rather, developed his own unique dietary approach to enhance his immune system. In this informative video, Jerry shares his personal experiences and provides his recipe for healthy living. You will learn about the crucial importance of minerals, which foods to choose for your best health requirements and what to avoid. After viewing this video you’ll realize the remarkable value of food in building good foundations, and providing buffers, to keep your body healthy.
Topics of the first video include:
- Why we are losing the ‘war’ on Cancer
- Metastasis kills 90% of the cancer patients; 50% die of cachexia (wasting disease).
- The virtue of the immune system in combating disease, including cancer.
- Chemotherapy agents MOP and CHOP are derivatives of WWI mustard gas.
- Angiogenesis and why cutting out the primary tumor is bad.
- Obesity, diabetes and the sugar consumption explosion.
- The greatest of health threats called Iatrogenic disease – illness caused by modern medicine.
- The superficiality of regular medicine with regards to the US cancer patient.
- Negative synergy of cocktails of different toxins.
- Why Prunes and Eggs are healthy foods.
- Selenium the antidote to mercury.
- The benefits of resveratrol.
- The benefits of Blueberries, Strawberries, Raspberries, Cranberries, Apples, Elderberries, Black Cherries, Lycopene, Pumpkins.
- How foods barely contain minerals in the US.
- Vegetables of the cross/cruciferous vegetables – “nr 1 vegetables in protecting against cancer”.
- Why antacids are not the answer to your stomach troubles.
Check out the accompanying resources page for slides and food advice.
Notes: (blue bold-faced emphasis is all mine)
The Physicians’ Desk Reference (PDR) is a commercially published compilation of manufacturers’ prescribing information (package insert) on prescription drugs, updated annually. While designed to provide physicians with the full legally mandated information relevant to writing prescriptions (just as its name suggests), it is widely available in libraries and bookstores, widely used by other medical specialists, and in significant part valuable to consumers. It is financially supported in part by pharmaceutical manufacturing corporations which create drugs listed within its pages.
Since the late 20th century, a consumer edition has been offered at a much reduced price. Electronic editions are available on CD-ROM and the World Wide Web to subscribers. PDR is owned by the Thomson Corporation of Toronto.
The main edition is usable by determined consumers in conjunction with a medical dictionary. Many practicing physicians receive free copies of the PDR and are willing to give a patient a previous year’s edition when they receive their new one but a recent edition generally differs from the current one by the absence of the drugs introduced during the course of the intervening year.
A material safety data sheet (MSDS) is a form containing data regarding the properties of a particular substance. An important component of product stewardship and workplace safety, it is intended to provide workers and emergency personnel with procedures for handling or working with that substance in a safe manner, and includes information such as physical data (melting point, boiling point, flash point, etc.), toxicity, health effects, first aid, reactivity, storage, disposal, protective equipment, and spill handling procedures. The exact format of an MSDS can vary from source to source within a country depending on how specific is the national requirement.
MSDS (Material Safety Data Sheets) are a widely used system for cataloging information on chemicals, chemical compounds, and chemical mixtures. MSDS information may include instructions for the safe use and potential hazards associated with a particular material or product. MSDS can be found anywhere chemicals are being used.
At Rational Therapeutics, we believe every cancer and every cancer patient is unique. With our ex-vivo analyses (EVA) of living tumor cells, we provide a “real time” snapshot (functional profile), of how your cancer behaves when exposed to a variety of chemotherapeutic drugs and combinations. We are able to identify the agents that will work most effectively, eliminate drugs that are likely not to work, and save valuable time in the treatment process. “Functional Profiling” is the only approach that can answer these complex questions.
Type: Public Company
Address: 521 W. 57th Street, 6th Floor, New York, New York 10019, U.S.A.
Telephone: (212) 698-0300
Fax: (212) 258-2137
Sales: $138.2 million (2000)
Stock Exchanges: NASDAQ
Ticker Symbol: IMPH
NAIC: 621511 Medical Laboratories
SIC: 8071 Medical Laboratories
Based in New York City, IMPATH Inc. describes itself as a cancer information company. Originally founded to conduct cancer testing and analysis on an outsourcing basis for smaller hospitals that lacked the sophisticated technology and requisite personnel of larger institutions, IMPATH has taken advantage of a resulting database of more than 800,000 cases and other unique resources to expand its product offerings. The company’s Physician Services business employs its testing expertise to assist physicians in determining both a prognosis of various forms of cancer as well as an appropriate treatment plan and the monitoring of recovery. Although Physician Services still accounts for nearly 90 percent of the company’s revenues, IMPATH is optimistic about the potential of its Predictive Oncology unit, which uses its large database of case histories and tissue and serology archive linked to outcomes information to assist genomics, biotechnology, and pharmaceutical companies in the development of targeted drugs made possible by the mapping of the human genetic code. Through its Information Services business, IMPATH licenses software to some 600 hospitals to enable them to maintain their mandated cancer registries, while helping IMPATH to continue to populate its database of treatment and outcomes information, now totaling some two million patients.
Definition of IPT: IPT (Insulin Potentiation Therapy) is a simple medical procedure that uses the hormone insulin, followed by glucose, to deliver drugs better, and to make them work more effectively, in smaller doses, with reduced or no side effects.
Other insulin-related mechanisms (such as detoxification, immune stimulation, and angiogenesis) may also be involved.
— without major side effects.
Gentle cancer treatment
— without trauma.
Infectious disease treatment: faster and more effective.
Could fight drug resistance.
Available to patients today, with no need to wait years for government (FDA) approval.
More than 70 years of successful use.
With IPT, regular drugs act like “super” drugs, for treatment of many different diseases.
These are observations that some IPT doctors have reported for many years.
Supported by scientific papers, and reports from many doctors. However, despite more than 140 years of cumulative reported IPT success, and billions of dollars spent on other medical research, no clinical or laboratory research on IPT has been done or funded… yet.
IPT deserves laboratory studies and clinical trials.
“The second discovery of insulin.” ™